Effect of Apollo Wearable on Long COVID-19 Symptoms.

Status unconfirmed

Conditions studied: Post-acute Sequelae of SARS-COV-2 Infection

In brief

The purpose of this study is to examine how Apollo wearable use impacts symptoms and quality of life following long COVID.

Key facts

Study ID

NCT06097442

Run by

The Board of Medicine

People needed

200

Starts

2023-10-23

Expected to finish

2025-03-01

Last updated by the study team

2023-10-27

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• New purchasers of Apollo who haven't started using their Apollo device or previous users of Apollo who haven't used Apollo in the preceding 14 days.
• Age 18 years or over
• Currently experiencing symptoms related to long-COVID according to PASC (self report).
• Must be experiencing PASC symptoms in at least one of the following domains:
• Respiratory-related symptoms Fatigue-related symptoms Neurologic-related symptoms Psychiatric-related symptoms Sleep-related symptoms Change in quality of life/functional status

You may not qualify if…

• Inability to use or access a compatible Android or iOS smartphone
• Are unable to complete consent and questionnaires written in English
• Current resident of a European Union (EU) country

Where it is running

• The Board of Medicine — Pittsburgh, Pennsylvania, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.